Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radioembolization in Elderly/Fragile Patients With Unresectable Livermetastases of Colorectal Cancer
NCT05092880Phase 2Terminated
- Start
- Jun 2022
- Primary completion
- Sep 2025
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in colorectal cancer (CRC) (2 arms). Primary endpoint: Progression-Free Survival at 4 years. Started Jun 2022; status: terminated.
02
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05092880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05092880.